Abstract: A non-naturally occurring microbial organism having an aniline pathway includes at least one exogenous nucleic acid encoding an aniline pathway enzyme expressed in a sufficient amount to produce aniline. The aniline pathway includes (1) an aminodeoxychorismate synthase, an aminodeoxychorismate lyase, and a 4-aminobenzoate carboxylyase or (2) an anthranilate synthase and an anthranilate decarboxylase. A method for producing aniline, includes culturing these non-naturally occurring microbial organisms under conditions and for a sufficient period of time to produce aniline.
Abstract: The present invention relates to a method of producing a recombinant polypeptide in a filamentous fungus which is genetically modified to decrease or eliminate the activity of cellulase regulator 1 (CLR1) and to express the recombinant polypeptide. The method further relates to a filamentous fungus Myceliophthora thermophila, which is genetically modified to decrease or eliminate the activity of CLR1 and to the use of this filamentous fungus in the production of a recombinant polypeptide.
Type:
Grant
Filed:
December 2, 2016
Date of Patent:
March 24, 2020
Assignee:
BASF SE
Inventors:
Stefan Haefner, Andreas Thywissen, Holger Hartmann, Nico Boehmer
Abstract: Polypeptide scaffolds comprising enzymatic proteins are provided. The enzymatic polypeptide scaffolds comprise heterologous enzymes to form a heterologous metabolic pathway, and can be targeted to a substrate through a surface anchoring domain. The enzymatic polypeptide scaffolds leverage the high specificity and affinity protein/protein interaction between the cohesins and dockerins of microorganismal cellulosomes to form custom enzymatic arrays.
Type:
Grant
Filed:
March 23, 2017
Date of Patent:
March 3, 2020
Assignee:
Alliance for Sustainable Energy, LLC
Inventors:
Yannick J. Bomble, Michael E. Himmel, Jeffrey Linger, Roman Brunecky, John Aikens
Abstract: Described herein are oligosaccharyl transferases for use in N-glycosylating proteins of interest in vitro and in host cells. Methods for using such oligosaccharyl transferases, nucleic acids encoding such oligosaccharyl transferases, and host cells comprising such oligosaccharyl transferases are also provided herein. Glycoconjugates generated by using such oligosaccharyl transferases are also provided herein.
Type:
Grant
Filed:
November 1, 2018
Date of Patent:
March 3, 2020
Assignee:
GlaxoSmithKline Biologicals SA
Inventors:
Jurgen Haas, Julian Ihssen, Michael Thomas Kowarik, Torsten Franz Schwede, Linda Christiane Thöny-Meyer
Abstract: Provided are a microorganism of the genus Escherichia for producing O-succinylhomoserine and a method for producing O-succinylhomoserine using the same.
Type:
Grant
Filed:
January 22, 2015
Date of Patent:
February 25, 2020
Assignee:
CJ CHEILJEDANG CORPORATION
Inventors:
Su Jin Choi, Kuk Ki Hong, Young Lyeol Yang, Min Sun Kang, Hye Min Park, Gyuhyeon Song, Jong Hyun Yoon
Abstract: The present invention relates to genetically engineered organisms, especially microorganisms such as bacteria and yeasts, for the production of added value bio-products such as specialty saccharide, activated saccharide, nucleoside, glycoside, glycolipid or glycoprotein. More specifically, the present invention relates to host cells that are metabolically engineered so that they can produce said valuable specialty products in large quantities and at a high rate by bypassing classical technical problems that occur in biocatalytical or fermentative production processes.
Type:
Grant
Filed:
July 29, 2016
Date of Patent:
February 25, 2020
Assignee:
INBIOSE N.V.
Inventors:
Jo Maertens, Joeri Beauprez, Marjan De Mey
Abstract: The present disclosure provides for production of succinic acid from organic waste or biogas or methane using recombinant methanotrophic bacterium. In one embodiment, the recombinant methanotrophic bacterium includes exogenous nucleic acid(s) or gene(s) encoding for specified enzymes. In a further embodiment, succinic acid producing capacity of the recombinant methanotrophic bacterium is increased above the basal level by overexpression or/and downregulation of selected gene(s). In another embodiment, a process of producing succinic acid using the recombinant methanotrophic bacterium is disclosed. The present invention successfully solves the problems in converting organic waste to a useful chemical thereby providing an environment-friendly and commercially viable solution for waste management.
Abstract: The present disclosure relates generally to an entomopathogenic fungi, Metarhiziuim spp, and its use to control invertebrate pests of agricultural crops, in particular, invertebrate pests which affect cotton crops.
Type:
Grant
Filed:
September 23, 2016
Date of Patent:
February 18, 2020
Assignees:
Cotton Research and Development Corporation, The Crown in right of the State of New South Wales acting through the Department of Primary Industries, as office of the NSW Department of Industry, Skills and Regional Development
Abstract: A bacterium that constitutively produces monophosphoryl lipid A (MLA) and a method of producing MLA by using the bacterium may simply produce MLA and a derivative thereof without acid hydrolysis, reduce a probability of natural mutation, and increase yields of MLA and a derivative thereof by constitutive expression of the MLA and derivative thereof.
Type:
Grant
Filed:
July 3, 2018
Date of Patent:
February 11, 2020
Assignee:
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
Inventors:
Hak Suk Chung, Yu Hyun Ji, Jin Su An, Ick Chan Kwon, Eun Gyeong Yang
Abstract: The present invention relates to non-naturally occurring polypeptides useful for preparing armodafinil, polynucleotides encoding the polypeptides, and methods of using the polypeptides. The non-naturally occurring polypeptides of the present invention are effective in carrying out biocatalytic conversion of the (i) 2-(benzhydrylsulfinyl)acetamide to (?)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide (armodafinil), or (ii) benzhydryl-thioacetic acid to (R)-2-(benzhydrylsulfinyl)acetic acid, which is a pivotal intermediate in the synthesis of armodafinil, in enantiomeric excess.
Type:
Grant
Filed:
July 29, 2019
Date of Patent:
February 11, 2020
Assignee:
Codexis, Inc.
Inventors:
Ee Lui Ang, Oscar Alvizo, Behnaz Behrouzian, Michael D. Clay, Steven J. Collier, Ellen D. Eberhard, Fu Fan, Shiwei Song, Derek J. Smith, Magnus Widegren, Robert Wilson, Junye Xu, Jun Zhu
Abstract: The invention provides methods to identify, diagnose, and treat kidney cancer through the detection of expression and/or activity of anaplastic lymphoma kinase (ALK). The detection of the presence of a polypeptide with ALK kinase activity (e.g., by detecting expression and/or activity of the polypeptide), identify those kidney cancers that are likely to respond to an ALK-inhibiting therapeutic.
Type:
Grant
Filed:
September 3, 2015
Date of Patent:
February 4, 2020
Assignee:
CELL SIGNALING TECHNOLOGY, INC.
Inventors:
Herbert Haack, Katherine Eleanor Crosby, Victoria McGuinness Rimkunas, Matthew Ren Silver
Abstract: Presented herein are transposase enzymes and reaction conditions for improved fragmentation and tagging of nucleic acid samples, in particular altered transposases and reaction conditions which exhibit improved insertion sequence bias, as well as methods and kits using the same.
Type:
Grant
Filed:
April 29, 2019
Date of Patent:
January 28, 2020
Assignee:
ILLUMINA, INC.
Inventors:
Christian Gloeckner, Amirali Kia, Erin Bomati, Molly He, Haiying Li Grunenwald, Scott Kuersten, Trina Faye Osothprarop, Darin Haskins, Joshua Burgess, Anupama Khanna, Daniel Schlingman, Ramesh Vaidyanathan
Abstract: Disclosed are methods for ergothioneine biosynthesis. More particularly, the present disclosure relates to methods for microbial ergothioneine biosynthesis. The present disclosure relates generally to engineered host cells and methods for producing ergothioneine. More particularly, the present disclosure relates to an engineered host cell and methods for microbial ergothioneine biosynthesis using the engineered host cell.
Abstract: The present invention relates to a method of reducing serine for asparagine misincorporation in a protein produced by a culture of cells in a cell culture method, the method comprising the addition of asparagine and iron to the cell culture medium.
Type:
Grant
Filed:
March 13, 2017
Date of Patent:
January 7, 2020
Assignee:
ARES TRADING S.A.
Inventors:
Thomas Solacroup, Matthieu Stettler, Hervé Broly
Abstract: Disclosed herein are split inteins, fused proteins of split inteins, and methods of using split inteins to efficiently purify and modify proteins of interest.
Type:
Grant
Filed:
November 10, 2017
Date of Patent:
January 7, 2020
Assignee:
THE TRUSTEES OF PRINCETON UNIVERSITY
Inventors:
Tom W. Muir, Miquel Vila-Perello, Zhihua Liu, Neel H. Shah
Abstract: The present invention discloses a Nicotinamide phosphoribosyltransferase (nampt) mutant and use thereof. The present invention relates to a nicotinamide phosphoribosyltransferase (Nampt) mutant artificially obtained through genic site-directed mutation. An object of the present invention is to provide a Nampt mutant having a catalytic activity higher than that of a conventional wild type parent, wherein the enzymatic activity of the Nampt mutant provided in the present invention is 1.2-6.9 times of the enzymatic activity of the parent.
Abstract: The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.
Abstract: Bacteriophage Insensitive Mutants (BIMs) of three Streptococcus thermophilus parent strains were generated and characterized for phage sensitivity, sedimentation rate, cell chain length, phage adsorption and CRISPR loci alterations. Several BIMs showed an altered sedimentation phenotype as well as an increase cell chain length, reduced phage sensitivity, reduced phage adsorption and 100% identity in three CRISPR loci. The results show that the derived BIMs have become phage-resistant through a mechanism other than CRISPR.
Type:
Grant
Filed:
July 2, 2018
Date of Patent:
December 31, 2019
Assignee:
DSM IP ASSETS B.V.
Inventors:
Roelof Hendrik Matthijs Kouwen, Pim Van Hee, Douwe Van Sinderen, Brian McDonnell, Jennifer Mahony
Abstract: The present invention provides methods for improving microbial tolerance to alpha olefin compounds, host cells having increased tolerance to such compounds, and method of using the host cells to produce alpha olefin compounds.
Type:
Grant
Filed:
April 29, 2015
Date of Patent:
December 24, 2019
Assignees:
The Regents of the University of California, Total Marketing Services